Ensign Peak Advisors’s Novavax NVAX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Sell |
46,450
-5,950
| -11% | -$37.5K | ﹤0.01% | 1656 |
|
|
2025
Q1 | $336K | Hold |
52,400
| – | – | ﹤0.01% | 1629 |
|
|
2024
Q4 | $421K | Buy |
52,400
+7,500
| +17% | +$60.3K | ﹤0.01% | 1642 |
|
|
2024
Q3 | $567K | Hold |
44,900
| – | – | ﹤0.01% | 1572 |
|
|
2024
Q2 | $568K | Buy |
44,900
+1,300
| +3% | +$16.5K | ﹤0.01% | 1567 |
|
|
2024
Q1 | $208K | Sell |
43,600
-2,200
| -5% | -$10.5K | ﹤0.01% | 1704 |
|
|
2023
Q4 | $220K | Buy |
45,800
+1,150
| +3% | +$5.52K | ﹤0.01% | 1717 |
|
|
2023
Q3 | $323K | Buy |
+44,650
| New | +$323K | ﹤0.01% | 1678 |
|
|
2022
Q4 | – | Sell |
-69,335
| Closed | -$1.26M | – | 2078 |
|
|
2022
Q3 | $1.26M | Buy |
69,335
+17,775
| +34% | +$324K | ﹤0.01% | 956 |
|
|
2022
Q2 | $2.65M | Buy |
51,560
+6,740
| +15% | +$347K | 0.01% | 704 |
|
|
2022
Q1 | $3.3M | Buy |
44,820
+15,420
| +52% | +$1.14M | 0.01% | 707 |
|
|
2021
Q4 | $4.21M | Buy |
29,400
+12,765
| +77% | +$1.83M | 0.01% | 714 |
|
|
2021
Q3 | $3.45M | Buy |
16,635
+6,231
| +60% | +$1.29M | 0.01% | 813 |
|
|
2021
Q2 | $2.21M | Buy |
10,404
+1,400
| +16% | +$297K | ﹤0.01% | 1072 |
|
|
2021
Q1 | $1.63M | Sell |
9,004
-6,061
| -40% | -$1.1M | ﹤0.01% | 1208 |
|
|
2020
Q4 | $1.68M | Sell |
15,065
-28,066
| -65% | -$3.13M | ﹤0.01% | 1162 |
|
|
2020
Q3 | $4.67M | Buy |
+43,131
| New | +$4.67M | 0.01% | 650 |
|